CLINICAL_TRIALS
trial_result
· 2014-05-28
Clinical Trial Update: Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression [Phase 2]
Summary
A Phase 2 trial evaluating Lu AA39959 for bipolar depression has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Bipolar Disorder | Phase 2 | Status: TERMINATED